181 related articles for article (PubMed ID: 34588805)
1. IRF4 is Correlated with the Conversion to a Th17-Like Phenotype in Regulatory T Cells from the Malignant Pleural Effusion.
Yu W; Ji N; Gu C; Yao J; Ding M; Zhou D; Huang M; Zhang M
Int J Gen Med; 2021; 14():6009-6019. PubMed ID: 34588805
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels.
Yu WQ; Ji NF; Gu CJ; Sun ZX; Wang ZX; Chen ZQ; Ma Y; Wu ZZ; Wang YL; Wu CJ; Ding MD; Dai GH; Yao J; Jin RR; Huang M; Zhang MS
Chin Med J (Engl); 2019 Nov; 132(22):2705-2715. PubMed ID: 31725455
[TBL] [Abstract][Full Text] [Related]
3. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
4. IRF4-mediated Treg phenotype switching can aggravate hyperoxia-induced alveolar epithelial cell injury.
Langyue H; Ying Z; Jianfeng J; Yue Z; Huici Y; Hongyan L
BMC Pulm Med; 2024 Mar; 24(1):130. PubMed ID: 38491484
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis.
Ye LL; Peng WB; Niu YR; Xiang X; Wei XS; Wang ZH; Wang X; Zhang SY; Chen X; Zhou Q
Ann Transl Med; 2020 Dec; 8(24):1647. PubMed ID: 33490159
[TBL] [Abstract][Full Text] [Related]
6. Th17/Treg imbalance in malignant pleural effusion.
Yang WB; Ye ZJ; Xiang F; Zhang JC; Zhou Q
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):27-32. PubMed ID: 23392703
[TBL] [Abstract][Full Text] [Related]
7. Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia.
Tang M; Cheng L; Li F; Wu B; Chen P; Zhan Y; Hua F; Min Z; Ke Y; Liu C; Yuan L; Sun L; Chen H; Ji L; Cheng Y
Biomed Res Int; 2019; 2019():1050285. PubMed ID: 31380412
[TBL] [Abstract][Full Text] [Related]
8. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
9. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Müller M; Herrath J; Malmström V
Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
[TBL] [Abstract][Full Text] [Related]
10. Decreased frequency of regulatory T cells and level of helios gene expression in secondary progressive multiple sclerosis patients: Evidence about the development of multiple sclerosis.
Tarighi M; Shahbazi M; Saadat P; Daraei A; Alizadeh Khatir A; Rahimifard K; Mohammadnia-Afrouzi M
Int Immunopharmacol; 2023 Mar; 116():109797. PubMed ID: 36738680
[TBL] [Abstract][Full Text] [Related]
11. [Expression of CC-chemokine ligand 18 (CCL18) in the serum and pleural effusion of non-small-cell lung cancer patients and its regulatory effect on the differentiation of monocyte-derived dendritic cells].
Chen L; Zhou Q; Zhong F; Wang Q; Fang Y; Yang K; Guan S
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):823-7. PubMed ID: 25620478
[TBL] [Abstract][Full Text] [Related]
12. [Role of Imbalance between Th17 Cells and Treg Cells in the Pathogenesis of Children with Henoch-Schonlein Purpura].
Wang Q; Shi YY; Cao M; Dong W; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1391-6. PubMed ID: 26524044
[TBL] [Abstract][Full Text] [Related]
13. Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells.
Namdari H; Izad M; Rezaei F; Amirghofran Z
Int Immunopharmacol; 2019 Feb; 67():417-426. PubMed ID: 30586665
[TBL] [Abstract][Full Text] [Related]
14. [The number of FOXP3
He L; Lu H; Zhu Y; Jiang J; Ju H; Qiao Y; Wei S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jan; 40(1):7-12. PubMed ID: 38246171
[TBL] [Abstract][Full Text] [Related]
15. Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.
Prado-Garcia H; Romero-Garcia S; Rumbo-Nava U; Lopez-Gonzalez JS
Anticancer Res; 2015 Mar; 35(3):1529-35. PubMed ID: 25750307
[TBL] [Abstract][Full Text] [Related]
16. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287
[TBL] [Abstract][Full Text] [Related]
17. Upregulated TIGIT
Lin F; Hu X; Zhang Y; Ye S; Gu Y; Yan B; Wang L; Jiang Y
Mol Immunol; 2022 Jul; 147():40-49. PubMed ID: 35504057
[TBL] [Abstract][Full Text] [Related]
18. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
20. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
